Live Breaking News & Updates on Hyderabad Based Pharmaceutical

Stay updated with breaking news from Hyderabad based pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biological E's 14-Valent Pneumococcal Conjugate Vaccine

Hyderabad: Hyderabad-based Pharmaceutical and Vaccine Company Biological E. Limited (BE), announced its Pharmaceutical and Vaccine Company that its 14-valent paediatric Pneumococcal Conjugate Vaccine, (Investigational Pneumococcal Polysaccharide Conjugate Vaccine PCV14) against S. pneumoniae infection received approval from the Drugs Controller General of India (DCGI) for ....

Andhra Pradesh , Mahima Datla , Vaccine Company , Vaccine Company Biologicale Limited , Hyderabad Based Pharmaceutical , Vaccine Company Biological , Pneumococcal Conjugate Vaccine , Drugs Controller General , Managing Director , Iologicales 14 Valent Pneumococcal Conjugate Vaccine , Biologicale Limited ,

DCGI approves 14-valent pneumococcal conjugate vaccine

Biological E. Limited (BE), a Hyderabad-based Pharmaceutical and Vaccine Company Friday announced that its 14-valent paediatric Pneumococcal Conjugate Vaccine, (Investigational Pneumococcal Polysaccharide Conjugate Vaccine PCV14) against S. . ....

Andhra Pradesh , Mahima Datla , Vaccine Company , Be Limited , Hyderabad Based Pharmaceutical , Vaccine Company Friday , Pneumococcal Conjugate Vaccine , Drugs Controller General , Managing Director ,

Granules India's Q2 net profit up 80 pc at INR 145 cr

Uniindia: Hyderabad, Oct 20 (UNI) Granules India’s net profit increased by 80 per cent at INR 145 crore in the second quarter ended September 30,2022 as against INR 81 crore in the corresponding period in the previous year. ....

United States , Andhra Pradesh , Krishna Prasad Chigurupati , Pharmaceuticals Ingredients , Granules India , Hyderabad Based Pharmaceutical , Pharmaceutical Formulation Intermediates , Managing Director , Granules India Limited ,

Biological E's Corbevax vaccine granted approval for use in children aged 12-18

The move makes Corbevax the second covid vaccine to be approved for administration to children in India ....

Andhra Pradesh , National Technical Advisory Group , Drugs Controller General , Hyderabad Based Pharmaceutical , Receptor Binding Domain , Corbevax Covid Vaccine , Corbevax Vaccine , Orbevax Biological E , Orbevax Covid Vaccine Biological E , Orbevax Vaccine Biological E , Biologicale Limited , Iologicale Limited Corbevax , Iologicale Limited Corbevax Vaccine , Iologicale Limited Corbevax Covid Vaccine , Orbevax Dcgi Approval , Orbevax Vaccine Dcgi Approval , Orbevax Covid Vaccine Dcgi Approval ,

Biological E's Corbevax vaccine granted approval for use in children aged 12-18

The move makes Corbevax the second covid vaccine to be approved for administration to children in India ....

Andhra Pradesh , National Technical Advisory Group , Drugs Controller General , Hyderabad Based Pharmaceutical , Receptor Binding Domain , Corbevax Covid Vaccine , Corbevax Vaccine , Orbevax Biological E , Orbevax Covid Vaccine Biological E , Orbevax Vaccine Biological E , Biologicale Limited , Iologicale Limited Corbevax , Iologicale Limited Corbevax Vaccine , Iologicale Limited Corbevax Covid Vaccine , Orbevax Dcgi Approval , Orbevax Vaccine Dcgi Approval , Orbevax Covid Vaccine Dcgi Approval ,